C3.ai, Inc. Securities Lawsuit Investigation

Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in securities fraud cases, is investigating potential claims against C3.ai, Inc. (NYSE: AI).

If you purchased or held C3.ai, Inc. securities between February 26, 2025 and August 08, 2025, you may be eligible to join this class action lawsuit and seek compensation for your losses.

About C3.ai, Inc.

C3.ai provides artificial intelligence solutions for enterprise clients across various industries, including supply chain, energy, and healthcare. C3.ai is known for its AI platform and suite of applications designed to help businesses leverage generative AI.

Founded in 2009 and based in Redwood City, CA, C3.ai employs over 1,300 people.

The Allegations

The class action lawsuit alleges that C3.ai and certain executives made materially false and misleading statements, or failed to disclose material adverse facts, regarding the company's growth prospects and the impact of the CEO’s health on business operations.

According to the complaint, despite public assurances that CEO Thomas Siebel was able to perform his role and that the company was on track to meet its revenue targets, Siebel’s health issues significantly impaired C3.ai’s ability to close deals and achieve projected revenues.

During the class period, which spans from February 26, 2025 to August 8, 2025, it is alleged that C3.ai repeatedly emphasized strong market demand and robust growth expectations. However, on August 8, 2025, the company announced disappointing preliminary financial results for the first quarter of fiscal 2026 and reduced its revenue guidance for the full year. The company attributed these results to the disruption caused by a reorganization and the CEO’s ongoing health problems.

Following this disclosure, C3.ai’s stock price dropped sharply, falling approximately 25.58% from $22.13 on August 8, 2025 to $16.47 on August 11, 2025. This significant decline reflected investor concern over the company’s true financial condition and its ability to deliver on previous promises.

Important Dates

• Class period: February 26, 2025 to August 8, 2025
• Complaint filed: August 22, 2025
• Lead plaintiff deadline: October 21, 2025

Your Rights and Next Steps

If you purchased or otherwise acquired C3.ai, Inc. securities during the class period, you have important legal rights. You may be eligible to participate as a member of the class action and seek compensation for your financial losses related to the alleged securities fraud.

As an investor, you have the option to:

• Join the class action lawsuit as a class member, which allows you to share in any potential recovery.
• Seek to be appointed as the lead plaintiff, which means you would represent the interests of all class members in the case. The deadline to apply for lead plaintiff status is October 21, 2025.
• Do nothing and remain a passive class member, but you may still benefit from any settlement or judgment if the lawsuit is successful.

Lawyers are ready to help guide you through the process, answer your questions, and ensure your rights are protected. It is important to act before the lead plaintiff deadline if you wish to take an active role in the case.

You May Be Entitled to Compensation

If you invested in C3.ai, Inc. securities between February 26, 2025 and August 8, 2025 and suffered losses following the stock price drop, you may be entitled to compensation. To find out if you qualify to participate in the class action lawsuit, complete the below form.

Lawyers are ready to help you understand your options and pursue recovery for your losses.